The Gross Margin of Myungmoon Pharm Co Ltd (017180.KS) is 54.76%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-12-31 | 54.76% |
| 2024-12-31 | 56.30% |
| 2023-12-31 | 56.23% |
| 2022-12-31 | 51.34% |
| 2021-12-31 | 43.06% |
| 2020-12-31 | 38.32% |
| 2019-12-31 | 45.82% |
| 2018-12-31 | 50.48% |
| 2017-12-31 | 56.52% |
| 2016-12-31 | 53.58% |